Activity

Filter

Cancel
Date Panel Item Activity
7 actions
BabyScreen+ newborn screening v1.9 CDKN2A Zornitza Stark Marked gene: CDKN2A as ready
BabyScreen+ newborn screening v1.9 CDKN2A Zornitza Stark Gene: cdkn2a has been classified as Red List (Low Evidence).
BabyScreen+ newborn screening v1.9 CDKN2A Zornitza Stark Phenotypes for gene: CDKN2A were changed from Melanoma to {Melanoma, cutaneous malignant, 2}, MIM# 155601
BabyScreen+ newborn screening v1.8 CDKN2A Zornitza Stark Classified gene: CDKN2A as Red List (low evidence)
BabyScreen+ newborn screening v1.8 CDKN2A Zornitza Stark Gene: cdkn2a has been classified as Red List (Low Evidence).
BabyScreen+ newborn screening v1.7 CDKN2A Zornitza Stark reviewed gene: CDKN2A: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: {Melanoma, cutaneous malignant, 2}, MIM# 155601; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
BabyScreen+ newborn screening v0.0 CDKN2A Zornitza Stark gene: CDKN2A was added
gene: CDKN2A was added to gNBS. Sources: Expert Review Amber,BabySeq Category B gene
Mode of inheritance for gene: CDKN2A was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes for gene: CDKN2A were set to Melanoma